Clinical trial
Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After…
NCT00166868 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00166868 |
|---|---|
| Title | Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia After the Kasai Portoenterostomy |
| Official title | Use of Probiotics to Prevent Cholangitis in Children With Biliary Atresia |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Biliary Atresia |
| Intervention type | Drug |
| Interventions | Lactobacillus casei rhamnosus (Lcr35), Neomycin |
| Enrollment | 30 |
| Start date | Dec 1, 2003 |
| Primary completion | Jan 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Sep 14, 2005 |
| Last update posted | Aug 21, 2013 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: